Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_assertion type Assertion NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_head.
- NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_assertion description "[Thirty-six adults with acute lymphoblastic leukemia (ALL) were treated with adriamycin, vincristine, prednisolone, and asparaginase for remission induction, followed by vincristine-adriamycin-cyclophosphamide consolidation courses, cranial irradiation, a short ara-C plus VM-26 pulse, and vincristine plus cyclophosphamide rotating weekly with ara-C plus VM-26 for three months (reinforced HEAV'D).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_provenance.
- NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_assertion evidence source_evidence_literature NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_provenance.
- NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_assertion SIO_000772 8144131 NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_provenance.
- NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_assertion wasDerivedFrom befree-2016 NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_provenance.
- NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_assertion wasGeneratedBy ECO_0000203 NP1333843.RAlwZ9ry3fob1m8FWgla4hCJDK20lglOqge71T6Zx9fY0130_provenance.